Dr. Reddys Laboratories Ltd.

United States Food & Drug Administration (USFDA) has completed a Pre-Approval Inspection (PAI) and issued Form 483 with two observations to Dr. Reddy's Laboratories. The USFDA issued observations after inspecting the company’s manufacturing facility FTO 11 located at Srikakulam in Andhra Pradesh. The inspection was conducted from June 30, 2022 to July 07, 2022. The company will address this within the stipulated timeline.

Dr. Reddy's Laboratories is a multinational pharmaceutical company based in Hyderabad, Telangana in India. It manufactures and markets a wide range of pharmaceuticals in India and overseas.